You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Human Herpesvirus-8/HHV8

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HHV8 and Solid Organ Transplantation

Recruiting
  • HHV8
  • +7 more
  • Diagnostic test for HHV8 exposure
  • Milan, Italy
    Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Mil
Oct 4, 2021

Chronic Fatigue Syndrome Trial in Stanford (valganciclovir)

Completed
  • Chronic Fatigue Syndrome
  • Stanford, California
    Stanford University Medical Center
May 23, 2022

Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,

Active, not recruiting
  • Lymphoproliferative Disorder
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Embryonic Development, Embryo Morphokinetics, Embryo Morphometry Trial in Maribor (Experimental intervention: 8-5-2% oxygen

Completed
  • Embryonic Development
  • +2 more
  • Experimental intervention: 8-5-2% oxygen gradient concentration in the incubator
  • Maribor, Slovenia
    University Medical Centre Maribor
Jun 9, 2023

Pain Trial in Vienna (Room temperature, Cold temperature, Lidocain)

Not yet recruiting
  • Pain
  • Room temperature
  • +6 more
  • Vienna, Austria
    Medical University of Vienna
Jul 6, 2023

Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily

Completed
  • Kaposi s Sarcoma (KS)
    • Palermo, Italy
      Universita Degli Studi Di Palermo
    May 7, 2020

    Respiratory Viral Infection Trial (SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel, BioFire Respiratory Panel 2.1)

    Not yet recruiting
    • Respiratory Viral Infection
    • SARS-COV-2, Influenza and RSV 8-Well MT-PCR Panel
    • BioFire Respiratory Panel 2.1
    • (no location specified)
    Jul 13, 2023

    Burkitt Lymphoma, KSHV-associated Multicentric Castleman Disease, DLBCL Trial in Kampala (Rituximab and Hyaluronidase Human,

    Recruiting
    • Burkitt Lymphoma
    • +2 more
    • Rituximab and Hyaluronidase Human
    • +8 more
    • Kampala, Uganda
      UCI-Fred Hutch Cancer Centre
    Mar 9, 2022

    Neuroblastoma Trial in Guangzhou (Naxitamab monotherapy, GM-CSF, Irinotecan)

    Recruiting
    • Neuroblastoma
    • Naxitamab monotherapy
    • +6 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Aug 31, 2023

    Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

    Recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +5 more
    • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Influenza, Human Trial (FLU Q-PAN H5N8 Formulation 1, AS03B, AS03A)

    Not yet recruiting
    • Influenza, Human
    • FLU Q-PAN H5N8 Formulation 1
    • +3 more
    • (no location specified)
    Jul 27, 2023

    Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab

    Recruiting
    • Lung Non-Small Cell Carcinoma
    • +10 more
    • Atezolizumab and Recombinant Human Hyaluronidase
    • Survey Administration
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Jan 31, 2023

    Kaposi Sarcoma, Human Immunodeficiency Virus, Immune Reconstitution Syndrome Trial in Mexico city (Valganciclovir,

    Completed
    Has Results
    • Kaposi Sarcoma
    • +2 more
    • Mexico city, Mexico
      Instituto Nacional de Cancerologia
    Nov 23, 2021

    Influenza, Human Trial in Feicheng City (Quadrivalent Influenza Virus Split Vaccine)

    Recruiting
    • Influenza, Human
    • Quadrivalent Influenza Virus Split Vaccine
    • Feicheng City, Shandong, China
      Tingting and Yu
    Aug 3, 2022

    Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Carcinoma Trial in Houston

    Active, not recruiting
    • Advanced Colorectal Carcinoma
    • +24 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 20, 2022

    Human Papilloma Virus Trial in Boston (Gardasil9)

    Recruiting
    • Human Papilloma Virus
    • Boston, Massachusetts
      Boston Medical Center
    Oct 1, 2022

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8

    Active, not recruiting
    Has Results
    • Anatomic Stage II Breast Cancer AJCC v8
    • +16 more
    • Durvalumab
    • Tremelimumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    HIV-infection/Aids, Human Herpesvirus 4 Infections, Cytomegalovirus Infections Trial (NRTIs, Darunavir, Ritonavir)

    Withdrawn
    • HIV-infection/Aids
    • +4 more
    • (no location specified)
    Nov 8, 2020

    Itch Trial in Aalborg (Doxepin Topical, Papain, Histamine)

    Completed
    • Itch
    • Doxepin Topical
    • +3 more
    • Aalborg, Nordjylland, Denmark
      Aalborg University
    Jul 19, 2022

    Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,

    Active, not recruiting
    • Lung Non-Small Cell Carcinoma
    • +9 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 22, 2022

    COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)

    Active, not recruiting
    • COL6A3 Positive
    • +3 more
    • Aldesleukin
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 22, 2022

    Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA

    Active, not recruiting
    • Human Papillomavirus-16 Positive
    • +20 more
    • DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
    • Durvalumab
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 11, 2022

    BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma, Locally Advanced Hepatocellular Carcinoma Trial in

    Recruiting
    • BCLC Stage B Hepatocellular Carcinoma
    • +9 more
    • Durvalumab
    • Tremelimumab
    • Duarte, California
      City of Hope Medical Center
    Aug 15, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +13 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Influenza, Human, Infections, Respiratory Tract Infections Trial in United States (aH5N8c on Day 1, aH5N6c on Day 1, aH5N8c on

    Not yet recruiting
    • Influenza, Human
    • +4 more
    • aH5N8c on Day 1
    • +4 more
    • Cullman, Alabama
    • +8 more
    May 15, 2023